Saluda Medical, Inc. (ASX:SLD)
0.590
-0.035 (-5.60%)
At close: Apr 29, 2026
Saluda Medical Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
| Cash & Equivalents | 151.43 | 54.5 | 71.79 | 166.74 |
| Cash & Short-Term Investments | 151.43 | 54.5 | 71.79 | 166.74 |
| Cash Growth | -9.19% | -24.09% | -56.94% | - |
| Receivables | 14.99 | 12.64 | 11.13 | 5.94 |
| Inventory | 44.74 | 43.33 | 28.98 | 16.81 |
| Prepaid Expenses | 5.17 | 4.04 | 4.3 | 4.51 |
| Other Current Assets | - | 2.8 | 0.7 | - |
| Total Current Assets | 216.33 | 117.32 | 116.9 | 194 |
| Property, Plant & Equipment | 7.72 | 8.33 | 9.08 | 10.55 |
| Other Long-Term Assets | 1.82 | 3.02 | 1.36 | 6.62 |
| Total Assets | 225.87 | 128.67 | 127.34 | 211.18 |
| Accounts Payable | 6.86 | 1.5 | 2.61 | 1 |
| Accrued Expenses | 23.45 | 23.06 | 17.84 | 13.34 |
| Short-Term Debt | - | 129.84 | - | - |
| Current Portion of Leases | 1.07 | 1.12 | 0.82 | 0.59 |
| Current Income Taxes Payable | 0.97 | 0.72 | 0.45 | 0.6 |
| Current Unearned Revenue | 1.4 | 0.63 | - | - |
| Total Current Liabilities | 33.74 | 156.86 | 21.72 | 15.52 |
| Long-Term Debt | 71.68 | 71.39 | 67.71 | 62.84 |
| Long-Term Leases | 2.34 | 2.77 | 3.25 | 3.96 |
| Other Long-Term Liabilities | 2.06 | 3.19 | 4.6 | 5.36 |
| Total Liabilities | 109.81 | 234.21 | 97.29 | 87.68 |
| Common Stock | 0 | 0 | 0 | 0 |
| Additional Paid-In Capital | 759.94 | 86.54 | 72.42 | 68.66 |
| Retained Earnings | -641.16 | -574.4 | -425.09 | -327.27 |
| Comprehensive Income & Other | -2.72 | -3.35 | -3.67 | -4.29 |
| Total Common Equity | 116.06 | -491.2 | -356.34 | -262.9 |
| Shareholders' Equity | 116.06 | -105.54 | 30.06 | 123.5 |
| Total Liabilities & Equity | 225.87 | 128.67 | 127.34 | 211.18 |
| Total Debt | 75.08 | 205.12 | 71.79 | 67.39 |
| Net Cash (Debt) | 76.34 | -150.62 | 0.01 | 99.35 |
| Net Cash Growth | -23.16% | - | -99.99% | - |
| Net Cash Per Share | 1.98 | -46.32 | 0.00 | 30.62 |
| Filing Date Shares Outstanding | 252.02 | 3.25 | 3.25 | 3.25 |
| Total Common Shares Outstanding | 252.02 | 3.25 | 3.25 | 3.25 |
| Working Capital | 182.59 | -39.55 | 95.18 | 178.48 |
| Book Value Per Share | 0.46 | -150.93 | -109.70 | -81.01 |
| Tangible Book Value | 116.06 | -491.2 | -356.34 | -262.9 |
| Tangible Book Value Per Share | 0.46 | -150.93 | -109.70 | -81.01 |
| Machinery | 8.37 | 7.8 | 6.86 | 6.41 |
| Leasehold Improvements | 3.22 | 3.14 | 3.28 | 3.05 |
Source: S&P Capital IQ. Standard template. Financial Sources.